Cargando…

Mitigating Antibiotic Resistance Emissions in the Pharmaceutical Industry: Global Governance and Available Techniques

Detalles Bibliográficos
Autores principales:	Han, Ziming, Feng, Haodi, Wang, Chen, Wang, Xuegong, Yang, Min, Zhang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689968/ https://www.ncbi.nlm.nih.gov/pubmed/38046642 http://dx.doi.org/10.46234/ccdcw2023.195

Ejemplares similares

Global Governance Mechanisms to Address Antimicrobial Resistance
por: Padiyara, Ponnu, et al.
Publicado: (2018)

Data Governance in the Dairy Industry
por: Cue, Roger, et al.
Publicado: (2021)

Mitigating pharmaceutical waste exposures: policy and program considerations
por: Amster, Eric D.
Publicado: (2016)

Creating healthy food environments through global benchmarking of government nutrition policies and food industry practices
por: Vandevijvere, Stefanie, et al.
Publicado: (2014)

Public health and the legal regulation of the pharmaceutical industry in Algeria
por: Alsamara, Tareck, et al.
Publicado: (2022)

Pharmaceutical industry representation on CIHR’s governing council
por: Ghali, William, et al.
Publicado: (2010)

Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
por: Qiu, Lan, et al.
Publicado: (2014)

The Pharmaceutical Industry and the Canadian Government: Folie à Deux
por: Lexchin, Joel
Publicado: (2017)

The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
por: Arpinelli, Fabio, et al.
Publicado: (2006)

Blockchains, Property Rights and Health Technology Assessment in the Pharmaceutical and Device (s) Industries
por: Langley, Paul C, et al.
Publicado: (2018)

History, Structure and Agency in Global Health Governance: Comment on "Global Health Governance Challenges 2016 – Are We Ready?"
por: Gill, Stephen, et al.
Publicado: (2016)

Power in global governance: an expanded typology from global health
por: Moon, Suerie
Publicado: (2019)

Call in the lawyers: mitigating the Global Gag Rule
por: Roose-Snyder, Beirne, et al.
Publicado: (2020)

Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective
por: Auby, Philippe
Publicado: (2008)

Powerful Allies and Weak Consensus: Towards a Deeper Understanding of how Health-Harming Industries Seek to Influence Global Health Governance: Comment on "Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases"
por: Zenone, Marco, et al.
Publicado: (2021)

Antibiotic geographies and access to medicines: Tracing the role of India's pharmaceutical industry in global trade
por: Bjerke, Lise
Publicado: (2022)

Accounting for all territorial emissions and sinks is important for development of climate mitigation policies
por: Lindroth, Anders, et al.
Publicado: (2021)

Business as Usual: A Lack of Institutional Innovation in Global Health Governance: Comment on "Global Health Governance Challenges 2016 – Are We Ready?"
por: Lee, Kelley
Publicado: (2016)

Global Farm Animal Production and Global Warming: Impacting and Mitigating Climate Change
por: Koneswaran, Gowri, et al.
Publicado: (2008)

Developing the latest framework to measure and incentivise pharmaceutical industry contributions to health research and development
por: Cole, Clarke B., et al.
Publicado: (2018)

China’s domestic industry redistribution facilitates carbon emissions mitigation
por: Zhang, Zhuoying, et al.
Publicado: (2023)

Global health governance: we need innovation not renovation
por: Smith, Richard, et al.
Publicado: (2017)

The need for a functional pharmaceutical industry in Sierra Leone: lessons from the COVID-19 pandemic
por: Conteh, Eugene, et al.
Publicado: (2022)

Using agrophotovoltaics to reduce carbon emissions and global rural poverty
por: Zhang, Huiming, et al.
Publicado: (2022)

Polycentrism in Global Health Governance Scholarship: Comment on "Four Challenges That Global Health Networks Face"
por: Tosun, Jale
Publicado: (2017)

Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance
por: Adebisi, Yusuff Adebayo
Publicado: (2023)

What can the Glasgow Declaration on Forests bring to global emission reduction?
por: Zhu, Yakun, et al.
Publicado: (2022)

Energy technology availability to mitigate future greenhouse gas emissions : conference proceedings.
Publicado: (1997)

The future of global health: restructuring governance through inclusive youth leadership
por: O'Sullivan, Brianne, et al.
Publicado: (2023)

The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs
por: Ravinetto, Raffaella, et al.
Publicado: (2018)

At the Intersection of Industry, Academia, and Government: How Do We Facilitate Productive Precision Livestock Farming in Practice?
por: Ramirez, Brett C., et al.
Publicado: (2019)

Integrating pharmaceutical systems strengthening in the current global health scenario: three ‘uncomfortable truths’
por: Hafner, Tamara, et al.
Publicado: (2020)

Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea
por: Lee, Munjae
Publicado: (2015)

Queen bee in a beehive: WHO as meta-governor in global health governance
por: Van Belle, Sara, et al.
Publicado: (2018)

Rise of monkeypox: Lessons from COVID-19 pandemic to mitigate global health crises
por: Ennab, Farah, et al.
Publicado: (2022)

Regional trade agreement burdens global carbon emissions mitigation
por: Tian, Kailan, et al.
Publicado: (2022)

A New Gilded Age, and What It Means for Global Health: Comment on "Global Health Governance Challenges 2016 – Are We Ready?"
por: Schrecker, Ted
Publicado: (2016)

The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)
por: Shah, Vinod P., et al.
Publicado: (2010)

Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
por: Hopkins, Ashley M., et al.
Publicado: (2018)

WAAR (World Alliance against Antibiotic Resistance): Safeguarding antibiotics
por: Carlet, Jean, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_domba1gv0ia5e32kcivhhhjvm2